280 related articles for article (PubMed ID: 26171025)
1. Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
Chen Z; Liu X; Hu Z; Wang Y; Liu M; Liu X; Li H; Ji R; Guo Q; Zhou Y
Oncol Lett; 2015 Jul; 10(1):329-336. PubMed ID: 26171025
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
[TBL] [Abstract][Full Text] [Related]
3. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
4. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
5. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
6. Screening and identification of differentially expressed microRNAs in diffuse large B-cell lymphoma based on microRNA microarray.
Gao HX; Li SJ; Wang MB; Yan SF; Cui WL; Ma ZP; Xue J; Sang W; Zhang W; Li XX
Oncol Lett; 2021 Nov; 22(5):753. PubMed ID: 34539857
[TBL] [Abstract][Full Text] [Related]
7. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated microRNA expression profiles in gastric cancer cells with high peritoneal metastatic potential.
Feng Y; Bai F; You Y; Bai F; Wu C; Xin R; Li X; Nie Y
Exp Ther Med; 2018 Dec; 16(6):4602-4608. PubMed ID: 30546395
[TBL] [Abstract][Full Text] [Related]
9. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
11. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
12. Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach.
Yan L; Jiao D; Hu H; Wang J; Tang X; Chen J; Chen Q
Exp Biol Med (Maywood); 2017 Apr; 242(7):709-717. PubMed ID: 28299977
[TBL] [Abstract][Full Text] [Related]
13. Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer.
Wang Z; Wang J; Yang Y; Hao B; Wang R; Li Y; Wu Q
J Exp Clin Cancer Res; 2013 Oct; 32(1):76. PubMed ID: 24422944
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200a-3p and GATA6 are abnormally expressed in patients with non-small cell lung cancer and exhibit high clinical diagnostic efficacy.
Yu J; He X; Fang C; Wu H; Hu L; Xue Y
Exp Ther Med; 2022 Apr; 23(4):281. PubMed ID: 35317445
[TBL] [Abstract][Full Text] [Related]
15. Targeted MicroRNA Profiling in Gastric Cancer with Clinical Assessement.
Pehlevan Özel H; Dinç T; Tiryaki RS; Keşküş AG; Konu Ö; Kayilioğlu SI; Coşkun F
Balkan J Med Genet; 2021 Nov; 24(2):55-64. PubMed ID: 36249523
[TBL] [Abstract][Full Text] [Related]
16. Reduced Levels of miR-28 and miR-200a Act as Predictor Biomarkers of Aggressive Clinicopathological Characteristics in Gastric Cancer Patients.
Jeddi F; Alipour S; Najafzadeh N; Dadashpour M; Pouremamali F; Sadeghi MR; Samadi N; Soozangar N; Khamaneh AM
Galen Med J; 2019; 8():e1329. PubMed ID: 34466494
[TBL] [Abstract][Full Text] [Related]
17. Potentially predictive microRNAs of gastric cancer with metastasis to lymph node.
Wu WY; Xue XY; Chen ZJ; Han SL; Huang YP; Zhang LF; Zhu GB; Shen X
World J Gastroenterol; 2011 Aug; 17(31):3645-51. PubMed ID: 21987613
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression profiling and target gene analysis in gastric cancer.
Xu C; Xie J; Liu Y; Tang F; Long Z; Wang Y; Luo J; Li J; Li G
Medicine (Baltimore); 2020 Sep; 99(37):e21963. PubMed ID: 32925730
[TBL] [Abstract][Full Text] [Related]
19. microRNA analysis of gastric cancer patients from Saudi Arabian population.
Bibi F; Naseer MI; Alvi SA; Yasir M; Jiman-Fatani AA; Sawan A; Abuzenadah AM; Al-Qahtani MH; Azhar EI
BMC Genomics; 2016 Oct; 17(Suppl 9):751. PubMed ID: 27766962
[TBL] [Abstract][Full Text] [Related]
20. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
